14.13 USD
+0.03 (+0.21%)
Last: Feb 10, 2026, 12:46 PM
Overall SLP gets a fundamental rating of 6 out of 10. We evaluated SLP against 35 industry peers in the Health Care Technology industry. SLP has an excellent financial health rating, but there are some minor concerns on its profitability. SLP is growing strongly while it is still valued neutral. This is a good combination!
1. Profitability
1.1 Basic Checks
- SLP had positive earnings in the past year.
- SLP had a positive operating cash flow in the past year.
- SLP had positive earnings in 4 of the past 5 years.
- In the past 5 years SLP always reported a positive cash flow from operatings.
1.2 Ratios
- With a Return On Assets value of -46.61%, SLP is not doing good in the industry: 68.57% of the companies in the same industry are doing better.
- Looking at the Return On Equity, with a value of -50.54%, SLP is in line with its industry, outperforming 48.57% of the companies in the same industry.
- SLP has a Return On Invested Capital of 4.45%. This is in the better half of the industry: SLP outperforms 74.29% of its industry peers.
- The Average Return On Invested Capital over the past 3 years for SLP is below the industry average of 6.63%.
- The last Return On Invested Capital (4.45%) for SLP is above the 3 year average (3.61%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -46.61% | ||
| ROE | -50.54% | ||
| ROIC | 4.45% |
ROA(3y)-12.88%
ROA(5y)-5.32%
ROE(3y)-13.51%
ROE(5y)-5.53%
ROIC(3y)3.61%
ROIC(5y)4.56%
1.3 Margins
- With an excellent Operating Margin value of 9.00%, SLP belongs to the best of the industry, outperforming 82.86% of the companies in the same industry.
- SLP's Operating Margin has declined in the last couple of years.
- The Gross Margin of SLP (59.60%) is comparable to the rest of the industry.
- SLP's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9% | ||
| PM (TTM) | N/A | ||
| GM | 59.6% |
OM growth 3Y-33.32%
OM growth 5Y-21.72%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.94%
GM growth 5Y-4.73%
2. Health
2.1 Basic Checks
- SLP has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- The number of shares outstanding for SLP has been increased compared to 1 year ago.
- The number of shares outstanding for SLP has been increased compared to 5 years ago.
- There is no outstanding debt for SLP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- SLP has an Altman-Z score of 16.71. This indicates that SLP is financially healthy and has little risk of bankruptcy at the moment.
- SLP has a better Altman-Z score (16.71) than 91.43% of its industry peers.
- SLP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 16.71 |
ROIC/WACC0.47
WACC9.49%
2.3 Liquidity
- A Current Ratio of 5.62 indicates that SLP has no problem at all paying its short term obligations.
- Looking at the Current ratio, with a value of 5.62, SLP belongs to the top of the industry, outperforming 85.71% of the companies in the same industry.
- SLP has a Quick Ratio of 5.62. This indicates that SLP is financially healthy and has no problem in meeting its short term obligations.
- SLP's Quick ratio of 5.62 is amongst the best of the industry. SLP outperforms 85.71% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.62 | ||
| Quick Ratio | 5.62 |
3. Growth
3.1 Past
- SLP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 50.00%, which is quite impressive.
- SLP shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 1.07% yearly.
- The Revenue has been growing slightly by 5.69% in the past year.
- Measured over the past years, SLP shows a quite strong growth in Revenue. The Revenue has been growing by 13.74% on average per year.
EPS 1Y (TTM)50%
EPS 3Y-1.12%
EPS 5Y1.07%
EPS Q2Q%200%
Revenue 1Y (TTM)5.69%
Revenue growth 3Y13.67%
Revenue growth 5Y13.74%
Sales Q2Q%-2.66%
3.2 Future
- The Earnings Per Share is expected to grow by 22.12% on average over the next years. This is a very strong growth
- The Revenue is expected to grow by 10.39% on average over the next years. This is quite good.
EPS Next Y-5.97%
EPS Next 2Y-1.9%
EPS Next 3Y3.05%
EPS Next 5Y22.12%
Revenue Next Year2.12%
Revenue Next 2Y4.05%
Revenue Next 3Y5.79%
Revenue Next 5Y10.39%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
- SLP is valuated rather expensively with a Price/Earnings ratio of 23.55.
- Based on the Price/Earnings ratio, SLP is valued a bit cheaper than the industry average as 77.14% of the companies are valued more expensively.
- Compared to an average S&P500 Price/Earnings ratio of 28.06, SLP is valued at the same level.
- With a Price/Forward Earnings ratio of 25.32, SLP can be considered very expensive at the moment.
- SLP's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. SLP is cheaper than 62.86% of the companies in the same industry.
- The average S&P500 Price/Forward Earnings ratio is at 27.86. SLP is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.55 | ||
| Fwd PE | 25.32 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, SLP is valued a bit cheaper than the industry average as 65.71% of the companies are valued more expensively.
- SLP's Price/Free Cash Flow ratio is rather cheap when compared to the industry. SLP is cheaper than 82.86% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 14.28 | ||
| EV/EBITDA | 16.89 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)22.05
EPS Next 2Y-1.9%
EPS Next 3Y3.05%
5. Dividend
5.1 Amount
- With a yearly dividend of 0.61%, SLP is not a good candidate for dividend investing.
- Compared to an average industry Dividend Yield of 0.60, SLP pays a better dividend. On top of this SLP pays more dividend than 91.43% of the companies listed in the same industry.
- With a Dividend Yield of 0.61, SLP pays less dividend than the S&P500 average, which is at 1.80.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.61% |
5.2 History
- SLP has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DP0%
EPS Next 2Y-1.9%
EPS Next 3Y3.05%
NASDAQ:SLP (2/10/2026, 12:46:14 PM)
14.13
+0.03 (+0.21%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)01-08 2026-01-08/amc
Earnings (Next)04-01 2026-04-01
Inst Owners79.38%
Inst Owner Change-0.37%
Ins Owners17.2%
Ins Owner Change-0.16%
Market Cap284.58M
Revenue(TTM)78.68M
Net Income(TTM)-64.25M
Analysts80
Price Target25.25 (78.7%)
Short Float %6.83%
Short Ratio3.14
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.61% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-18.28%
Min EPS beat(2)-77.15%
Max EPS beat(2)40.59%
EPS beat(4)3
Avg EPS beat(4)71.31%
Min EPS beat(4)-77.15%
Max EPS beat(4)321.12%
EPS beat(8)4
Avg EPS beat(8)23.48%
EPS beat(12)5
Avg EPS beat(12)8.75%
EPS beat(16)7
Avg EPS beat(16)5.82%
Revenue beat(2)2
Avg Revenue beat(2)1.06%
Min Revenue beat(2)0.77%
Max Revenue beat(2)1.36%
Revenue beat(4)4
Avg Revenue beat(4)1.01%
Min Revenue beat(4)0.63%
Max Revenue beat(4)1.36%
Revenue beat(8)6
Avg Revenue beat(8)0.57%
Revenue beat(12)7
Avg Revenue beat(12)-0.44%
Revenue beat(16)10
Avg Revenue beat(16)0.08%
PT rev (1m)7.61%
PT rev (3m)7.61%
EPS NQ rev (1m)-19.39%
EPS NQ rev (3m)33.9%
EPS NY rev (1m)-28.95%
EPS NY rev (3m)34.16%
Revenue NQ rev (1m)2.05%
Revenue NQ rev (3m)-1.2%
Revenue NY rev (1m)0.21%
Revenue NY rev (3m)0.6%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.55 | ||
| Fwd PE | 25.32 | ||
| P/S | 3.62 | ||
| P/FCF | 14.28 | ||
| P/OCF | 12.04 | ||
| P/B | 2.24 | ||
| P/tB | 5.21 | ||
| EV/EBITDA | 16.89 |
EPS(TTM)0.6
EY4.25%
EPS(NY)0.56
Fwd EY3.95%
FCF(TTM)0.99
FCFY7%
OCF(TTM)1.17
OCFY8.3%
SpS3.91
BVpS6.31
TBVpS2.71
PEG (NY)N/A
PEG (5Y)22.05
Graham Number9.23
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -46.61% | ||
| ROE | -50.54% | ||
| ROCE | 5.55% | ||
| ROIC | 4.45% | ||
| ROICexc | 6.18% | ||
| ROICexgc | 29.44% | ||
| OM | 9% | ||
| PM (TTM) | N/A | ||
| GM | 59.6% | ||
| FCFM | 25.32% |
ROA(3y)-12.88%
ROA(5y)-5.32%
ROE(3y)-13.51%
ROE(5y)-5.53%
ROIC(3y)3.61%
ROIC(5y)4.56%
ROICexc(3y)6.84%
ROICexc(5y)12.7%
ROICexgc(3y)60.47%
ROICexgc(5y)79.01%
ROCE(3y)4.51%
ROCE(5y)5.69%
ROICexgc growth 3Y-33.77%
ROICexgc growth 5Y-24.05%
ROICexc growth 3Y-37.37%
ROICexc growth 5Y-22.33%
OM growth 3Y-33.32%
OM growth 5Y-21.72%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.94%
GM growth 5Y-4.73%
F-Score6
Asset Turnover0.57
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 50.91% | ||
| Cap/Sales | 4.72% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 164.46% | ||
| Profit Quality | N/A | ||
| Current Ratio | 5.62 | ||
| Quick Ratio | 5.62 | ||
| Altman-Z | 16.71 |
F-Score6
WACC9.49%
ROIC/WACC0.47
Cap/Depr(3y)77.49%
Cap/Depr(5y)94.25%
Cap/Sales(3y)6%
Cap/Sales(5y)7.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)50%
EPS 3Y-1.12%
EPS 5Y1.07%
EPS Q2Q%200%
EPS Next Y-5.97%
EPS Next 2Y-1.9%
EPS Next 3Y3.05%
EPS Next 5Y22.12%
Revenue 1Y (TTM)5.69%
Revenue growth 3Y13.67%
Revenue growth 5Y13.74%
Sales Q2Q%-2.66%
Revenue Next Year2.12%
Revenue Next 2Y4.05%
Revenue Next 3Y5.79%
Revenue Next 5Y10.39%
EBIT growth 1Y33.64%
EBIT growth 3Y-24.21%
EBIT growth 5Y-10.96%
EBIT Next Year143.82%
EBIT Next 3Y43.31%
EBIT Next 5Y28.01%
FCF growth 1Y53.44%
FCF growth 3Y1.12%
FCF growth 5Y11.57%
OCF growth 1Y36.52%
OCF growth 3Y0.42%
OCF growth 5Y10.69%
SIMULATIONS PLUS INC / SLP FAQ
What is the ChartMill fundamental rating of SIMULATIONS PLUS INC (SLP) stock?
ChartMill assigns a fundamental rating of 6 / 10 to SLP.
Can you provide the valuation status for SIMULATIONS PLUS INC?
ChartMill assigns a valuation rating of 4 / 10 to SIMULATIONS PLUS INC (SLP). This can be considered as Fairly Valued.
How profitable is SIMULATIONS PLUS INC (SLP) stock?
SIMULATIONS PLUS INC (SLP) has a profitability rating of 4 / 10.
What is the financial health of SIMULATIONS PLUS INC (SLP) stock?
The financial health rating of SIMULATIONS PLUS INC (SLP) is 8 / 10.
Can you provide the expected EPS growth for SLP stock?
The Earnings per Share (EPS) of SIMULATIONS PLUS INC (SLP) is expected to decline by -5.97% in the next year.